Russell Investments Group
AXDX

Russell Investments Group’s Accelerate Diagnostics AXDX Stock Holding History

Russell Investments Group’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-13,658
Closed -$207K – 2895
2022
Q3 		$207K Buy
+13,658
New +$226K ﹤0.01% 2539
2022
Q1 		– Sell
-33,842
Closed -$1.77M – 2753
2021
Q4 		$1.77M Buy
+33,842
New +$1.88M ﹤0.01% 1865
2020
Q3 		– Sell
-2,160
Closed -$327K – 3181
2020
Q2 		$327K Buy
+2,160
New +$213K ﹤0.01% 2548
2017
Q3 		– Sell
-27,846
Closed -$7.62M – 2941
2017
Q2 		$7.62M Buy
+27,846
New +$7.55M 0.01% 1034
2017
Q1 		– Sell
-1,301
Closed -$282K – 2987
2016
Q4 		$282K Buy
+1,301
New +$309K ﹤0.01% 2635

Other funds holding AXDX

GAM
Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Russell Investments Group's AXDX Position: Q4 2022 in Review

Russell Investments Group sold out of Accelerate Diagnostics (AXDX) in Q4 2022, closing a stake of 13,658 shares — an estimated $207K sold.

Russell Investments Group first reported a position in AXDX in Q4 2016 and held it in 5 quarters. The position peaked at $7.62M in Q2 2017. 72 funds tracked by Wall St. Rank hold AXDX as of Q4 2022.

  • Russell Investments Group reported no remaining Accelerate Diagnostics position as of Q4 2022 after selling out during the quarter.
  • Russell Investments Group sold 13,658 Accelerate Diagnostics shares in Q4 2022, an estimated $207K.
  • Russell Investments Group first reported a position in Accelerate Diagnostics in Q4 2016 and held it in 5 quarters.
  • Russell Investments Group's Accelerate Diagnostics position peaked at $7.62M in Q2 2017.
  • 72 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q4 2022.

Based on Russell Investments Group's 13F filing for Q4 2022, filed 8 Feb 2023.